Repeat Ipsilateral Focused Ultrasound Thalamotomy after Tremor Recurrence: Safety, Efficacy, and Lesion Analysis
Movement Disorders · 2026
DOI: 10.1002/mds.70416 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2026. Verfasst von Adam C Glaser und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Thalamus, Essential Tremor, Tremor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background
Magnetic resonance imaging (MRI)‐guided focused ultrasound (MRgFUS) thalamotomy provides durable tremor control for most patients with essential tremor (ET) and tremor‐dominant Parkinson's disease (TdPD), but tremor can recur.
Objectives
To evaluate the safety, efficacy, and lesion characteristics of repeat MRgFUS thalamotomy for tremor recurrence.
Methods
We retrospectively analyzed patients undergoing repeat ipsilateral MRgFUS thalamotomy. Clinical Rating Scale for Tremor‐Part A (CRST‐A) assessed tremor severity preoperatively and 1 day, 1 week, 1 month, 3 months, and 1 year after retreatment. Outcomes, side effects, lesion volumes and locations, and treatment parameters were compared with initial procedures and an institutional one‐time MRgFUS cohort (n = 535).
Results
Thirty patients (26 ET, 4 TdPD) underwent repeat thalamotomy with ≥3 months follow‐up. Mean CRST‐A improved from 5.37 preoperatively to 0.27 at day 1 (94.9% improvement), 2.00 (64.4%) at 3 months, and 2.50 (38.8%) at 1 year (all P ≤ 0.003 vs. baseline). Tremor recurred at similar rates after initial and repeat treatments. Repeat lesions were larger (526.3 vs. 414.1 mm 3 , P = 0.025) and shifted anteriorly (+1.2 mm, P = 0.003). Initial lesion volume in retreatment patients was similar to the one‐time cohort. Compared with initial treatments, patients more often experienced any side effect at 1 month ( P = 0.023) and had more side effects at 1 month ( P < 0.001) and 3 months ( P = 0.014) after repeat treatment. Patient satisfaction was high and 85% of patients would choose retreatment again.
Conclusions
Repeat ipsilateral MRgFUS thalamotomy restored tremor control after recurrence and achieved high patient satisfaction, despite increased side effects after repeat treatment and similar tremor progression rates after initial and repeat procedures. © 2026 International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Neurosurgery, Boston Children's Hospital, Boston, Massachusetts, USA.
- Department of Neurology, Mass General Brigham, Boston, Massachusetts, USA.
- Department of Medicine, Channing Division of Network Medicine, Brigham & Women's Hospital/Harvard Medical School.
- Department of Radiology, Mass General Brigham, Boston, Massachusetts, USA.
- Institute for Network Stimulation, Department of Stereotactic and Functional Neurosurgery, University Hospital Cologne, Cologne, Germany.
ORCID-Profile: Adam C Glaser, Melissa M J Chua
Zitieren
APA
Glaser, A. C., Chua, M. M. J., Mazurek, M., Meyer, G., Heydarpour, M., McDannold, N., Horn, A., Rolston, J. D., & Cosgrove, G. R. (2026). Repeat Ipsilateral Focused Ultrasound Thalamotomy after Tremor Recurrence: Safety, Efficacy, and Lesion Analysis. Movement Disorders. https://doi.org/10.1002/mds.70416
Vancouver
Glaser AC, Chua MMJ, Mazurek M, Meyer G, Heydarpour M, McDannold N, et al. Repeat Ipsilateral Focused Ultrasound Thalamotomy after Tremor Recurrence: Safety, Efficacy, and Lesion Analysis. Movement Disorders. 2026. doi:10.1002/mds.70416
BibTeX
@article{Glaser2026,
author = {Glaser, Adam C and Chua, Melissa M J and Mazurek, Mercy and Meyer, Garance and Heydarpour, Mahyar and McDannold, Nathan and Horn, Andreas and Rolston, John D and Cosgrove, G Rees},
title = {Repeat Ipsilateral Focused Ultrasound Thalamotomy after Tremor Recurrence: Safety, Efficacy, and Lesion Analysis},
journal = {Movement Disorders},
year = {2026},
doi = {10.1002/mds.70416}
}
EUVIMED